A Reevaluation of the Role of IgM Non-HLA Antibodies in Cardiac Transplantation
Authors:
- Iman M. HamourIHIman M. Hamour
- Margaret M. BurkeMBMargaret M. Burke
- Balikrishnan MaheshBMBalikrishnan Mahesh
- Rachel E. StanfordRSRachel E. Stanford
- Saleem Haj-YahiaSHSaleem Haj-Yahia
- Derek R. RobinsonDRDerek R. Robinson
- Pradeep KaulPKPradeep Kaul
- Magdi H. YacoubMYMagdi H. Yacoub
- Nicholas R. BannerNBNicholas R. Banner
- Marlene L. RoseMRMarlene L. Rose
- 27 March 2009
- journal article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 87 (6) , 864-871
Abstract
Preexisting IgG antibodies to donor human leukocyte antigens (HLA) are a risk factor for rapid allograft rejection. However, non-HLA antibodies, of the IgM class, also called autoreactive antibodies, are not believed to affect graft survival. The aim of this study was to determine the incidence and clinical relevance of pretransplant lymphocytotoxic non-HLA IgM antibodies on long-term cardiac allograft survival. A retrospective study of 616 adult recipients of cardiac allografts, transplanted at this center between 1991 and 2003, has been performed. Antibodies in pretransplant sera were initially defined using complement-dependent cytotoxicity assays, and subsequently analyzed for HLA specificities using solid phase assays. HLA antibodies were present in 69 of 616 heart recipients (58 IgG, 11 IgM); in 22 of these, the antibodies were donor-specific. Non-HLA IgM antibodies were detected in 59 of 616 recipients who did not have HLA-specific antibodies; these patients had a 1, 2, 5, and 10 year survival of 55.9%, 54.2%, 49.9%, and 43.3% compared with 75.8%, 73.7%, 66.6%, and 52.8% for those without antibodies (P=0.0085 log-rank test). Multivariate analysis demonstrated pretransplant non-HLA IgM antibodies to be an independent risk factor for mortality (P=0.0001). Myocardial histology of postmortem heart and cardiac biopsies suggested an association with ischemic damage and “primary” allograft failure. We propose the hypothesis that the presence of cytotoxic IgM antibodies to non-HLAs before heart transplantation maybe a risk factor for early allograft failure.Keywords
This publication has 39 references indexed in Scilit:
- C4d Fixing, Luminex Binding Antibodies—A New Tool for Prediction of Graft Failure After Heart TransplantationAmerican Journal of Transplantation, 2007
- The detection and definition of IgM alloantibodies in the presence of IgM autoantibodies using flowPRA beadsHuman Immunology, 2003
- Identification of the nonclassical HLA molecules, mica, as targets for humoral immunity associated with irreversible rejection of kidney allografts1Transplantation, 2002
- FLOW CYTOMETRY-DETECTED IgG IS NOT A CONTRAINDICATION TO RENAL TRANSPLANTATIONTransplantation, 1999
- CORRELATION OF ELISA-DETECTED IgG AND IgA ANTI-HLA ANTIBODIES IN PRETRANSPLANT SERA WITH RENAL ALLOGRAFT REJECTION1Transplantation, 1996
- The effect of panel reactive antibodies and the donor specific crossmatch on graft survival after heart and heart-lung transplantationTransplant Immunology, 1993
- IMMUNOGLOBULIN CLASS AND SPECIFICITY OF ANTIBODIES CAUSING POSITIVE T CELL CROSSMATCHESTransplantation, 1986
- REACTIVITY OF AUTOLYMPHOCYTOTOXIC ANTIBODIES FROM DIALYSIS PATIENTS WITH LYMPHOCYTES FROM CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTSTransplantation, 1978
- SUCCESSFUL KIDNEY TRANSPLANT IN PATIENT WITH POSITIVE CROSSMATCH DUE TO AUTOANTIBODIESTransplantation, 1976
- Significance of the Positive Crossmatch Test in Kidney TransplantationNew England Journal of Medicine, 1969